Clinical Trials Directory

Trials / Sponsors / vTv Therapeutics

vTv Therapeutics

Industry · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingCadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 32024-06-14
TerminatedStudy of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance
Alzheimer Disease
Phase 22019-06-27
CompletedEvaluation of TTP399 in Patients With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 1 / Phase 22017-10-25
Terminated2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)
Alzheimer's Disease
Phase 32016-12-01
CompletedA Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
Type 2 Diabetes Mellitus
Phase 22015-12-01
TerminatedEvaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease
Alzheimer's Disease
Phase 32015-04-01
CompletedAdd Glucokinase Activator to Target A1c
Diabetes Mellitus, Type 2
Phase 22015-03-01
CompletedA Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Type 2 Diabetes Mellitus
Phase 22012-08-01
CompletedA 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes
Type 2 Diabetes Mellitus
Phase 1 / Phase 22011-11-01
CompletedA Safety Study of TTP4000 in Subjects With Alzheimer's Disease
Alzheimer's Disease
Phase 12011-10-01
TerminatedLeft Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulatio
Coagulation
Phase 22009-06-01
CompletedSafety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss
Obesity
Phase 22009-02-01
CompletedFactor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
Venous Thromboembolism, Embolism and Thrombosis, Hip Fractures
Phase 22005-01-01